"Would You Get Vaccinated against COVID-19?" The Picture Emerging from a Study on the Prevalence of SARS-CoV-2 Infection in the General Population of the Veneto Region.
COVID-19 vaccine
general population
point of view
questionnaire
vaccine acceptance
vaccine reluctance
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
25 Feb 2022
25 Feb 2022
Historique:
received:
27
01
2022
revised:
14
02
2022
accepted:
23
02
2022
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
27
3
2022
Statut:
epublish
Résumé
COVID-19 disease, caused by the SARS-CoV-2 virus, continues to cause high hospitalization and death rates. Vaccination campaigns have been key to controlling the pandemic, but vaccine hesitancy is on the rise. This study investigated the general population’s attitude to vaccination in Veneto (northeast Italy) in January 2021 as part of a study on the prevalence of SARS-CoV-2 infection. An ad hoc questionnaire collected 4467 respondents’ sociodemographic data and propensity to be vaccinated, and findings were analyzed using logistic multivariable regression. The 48.9% of respondents were male, and the mean age was 46.8 ± 16.0 years. Asked whether they would get vaccinated against COVID-19, 84.3% said yes, 5.0% were uncertain, and 10.7% said no. Vaccine acceptance was higher in males than in females (85.8% vs. 82.8%), in people 70+ years old (92.3%), and among people with more than 14 years of schooling (89.6%). Multivariable analysis with adjOR (95% CI) showed a significantly greater vaccine reluctance in females (0.68 (0.57−0.81)), people 30−49 or 50−69 years old (0.69 (0.54−0.87)), and (0.76 (0.58−0.99)); and those with <9 or 9−13 years of schooling (0.62 (0.46−0.82)), and (0.72 (0.57−0.91)). As people refusing vaccination undeniably hinder efforts to control the pandemic, specific strategies are needed to overcome their doubts.
Identifiants
pubmed: 35334997
pii: vaccines10030365
doi: 10.3390/vaccines10030365
pmc: PMC8951628
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Veneto Region
ID : DGR 1643 del 24/11/2020. "Project to assess the prevalence and spread of SARS-CoV-2 in the population" in: Bollettino Ufficiale Regione Veneto n. 193 del 15/12/2020
Références
Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 2):131-46
pubmed: 25759359
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Euro Surveill. 2018 May;23(22):
pubmed: 29871721
Disaster Med Public Health Prep. 2021 Dec 23;:1-9
pubmed: 34937599
Cureus. 2021 Jul 8;13(7):e16261
pubmed: 34268064
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3
pubmed: 33684019
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
Occup Environ Med. 2021 Apr;78(4):237-243
pubmed: 33127659
Front Public Health. 2021 Jul 01;9:700213
pubmed: 34277557
Allergy. 2021 Feb;76(2):428-455
pubmed: 33185910
BMJ Open. 2021 Jun 15;11(6):e048172
pubmed: 34130963
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Vaccines (Basel). 2020 Jun 05;8(2):
pubmed: 32516936
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Prev Med. 2022 Jan;154:106885
pubmed: 34774880
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS Med. 2020 Oct 15;17(10):e1003354
pubmed: 33057373
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccine. 2022 Jan 3;40(1):151-161
pubmed: 34863621
Vaccines (Basel). 2021 Jan 18;9(1):
pubmed: 33477725
Int J Environ Res Public Health. 2021 Oct 15;18(20):
pubmed: 34682584
Vaccines (Basel). 2021 Oct 25;9(11):
pubmed: 34835174
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Vaccine. 2014 Dec 5;32(51):6986-6991
pubmed: 25454867
Acta Biomed. 2020 Apr 10;91(3-S):135-140
pubmed: 32275278
Public Health. 2021 May;194:245-251
pubmed: 33965796
Infection. 2021 Jun;49(3):387-399
pubmed: 33284427